The global Emphysema market is rising continually, mainly due to the rising prevalence of the
condition. The market appears well-developed due to the availability of many novel treatments
and therapeutics. Also, there are various capable medical devices available in the market for
the diagnosis and treatment of Emphysema. The increasing access to the diagnostic services for
respiratory illness also fuels the growth of the market.
Request Sample Copy
According to Market Research Future (MRFR), the global Emphysema market is poised to
register a CAGR over 6.1% throughout the forecast period, creating a substantial revenue
pocket by the end of 2023. Rising cases of respiratory diseases such as chronic bronchitis and
COPD drive the growth of the market, predominantly.
Additionally, factors such as smoking and environmental pollution foster the market, increasing
the prevalence of the condition. On the other hand, lack of expertise required to manage the
disease is a major factor restricting the growth of the market.
Global Emphysema Market – Segments
The report is segmented into five market dynamics to widen the scope of understanding,
By Type: Centrilobular and Panlobular Emphysema.
By Diagnosis: Imaging Test (X-Ray, CT scan) and Lung Function Test, among others.
By Treatment: Medication (Antibiotics, Bronchodilators, others), Therapy, and Surgery, among
By End-user: Hospitals & Clinics and Surgical Centers, among others.
By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World.
Global Emphysema Market – Regional Analysis
North America leads the global Emphysema market due to the increasing prevalence of the
condition. The presence of well-developed healthcare sectors and several major players,
alongside, the high healthcare spending fosters the growth of the market. Besides, increasing
government support for research & development, rising numbers of imaging test & lung
function test conducted fo